Records containing: Metastatic Prostate Carcinoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2025-10-21
BRCAAway: A Randomized Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects
CLINICAL_TRIALS study record update · 2025-10-14
Phase I/II Study to Evaluate the Safety and Tolerability of Avelumab in Combination With Other Anti-Cancer Therapies in Patients With Advanced Malignancies
CLINICAL_TRIALS study record update · 2025-10-06
Phase 2 Study of Bright White Light During Treatment With ADT Combination Therapy in Men With Advanced Prostate Cancer to PreServe PHysIcal and MeNtal HEalth (SHINE)
CLINICAL_TRIALS study record update · 2025-10-01
GENTleMEN: Genetic Testing for Men With Metastatic Prostate Cancer
CLINICAL_TRIALS study record update · 2025-07-17
Molecular Imaging With Ga-68 DOTATATE PET to Investigate Neuroendocrine Differentiation in Prostate Cancer Patients
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2025-07-09
68Ga-PSMA-11 PET/CT for Screening Prior to 177Lu-PSMA-617 Therapy
CLINICAL_TRIALS study record update · 2025-05-20
Peer Genetic Coaches for Enhancing Genetic Testing Awareness, Navigation, and Delivery Among African American Men With Metastatic Prostate Cancer, The EXPAND Network
CLINICAL_TRIALS study record update · 2025-05-20
A First-in-Human, Phase I PET Imaging Study of 11C-YJH08, a Selective Glucocorticoid Receptor-Targeting Agent, in Patients With Advanced Solid Tumor Malignancies
CLINICAL_TRIALS study record update · 2025-05-14
Creatine Supplementation With Resistance Training: A Novel Approach to Improving Body Composition and Associated Health Outcomes Among Prostate Cancer Patients
CLINICAL_TRIALS study record update · 2025-05-08
A Phase 2 Study of M6620 (VX-970, Berzosertib) in Combination With Carboplatin Compared With Docetaxel in Combination With Carboplatin in Metastatic Castration-Resistant Prostate Cancer
CLINICAL_TRIALS study record update · 2025-03-30
A Randomized Phase 2 Study of Cediranib in Combination With Olaparib Versus Olaparib Alone in Men With Metastatic Castration Resistant Prostate Cancer
CLINICAL_TRIALS study record update · 2025-02-25
Immunogenic Priming With PSMA-Targeted Radioligand Therapy in Advanced Prostate Cancer: A Phase 1b Study of 177Lu-PSMA-617 in Combination With Pembrolizumab
CLINICAL_TRIALS study record update · 2025-01-16
18F-Fluciclovine PET CT as an Indicator of Therapeutic Response in Metastatic Prostate Carcinoma (M1PCa)
CLINICAL_TRIALS study record update · 2024-12-18
A Phase II Study With a Lead-in Safety Phase of Abiraterone in Combination With PDMX1001/Niclosamide in Castration-Resistant Prostate Cancer (CRPC)
CLINICAL_TRIALS study record update · 2024-11-29
[18F]Fluciclovine Companion Imaging Study to Radium-223 and Radiotherapy in Hormone-Naive Men With Oligometastatic Prostate Cancer to Bone (RROPE) Study
CLINICAL_TRIALS study record update · 2024-10-16
A Phase 2 Study of 68Ga-PSMA-11 PET in Patients With Metastatic Castration Resistant Prostate Cancer
CLINICAL_TRIALS study record update · 2024-07-16
Phase II Multi-Center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Castrate Resistant Prostate Cancer
CLINICAL_TRIALS study record update · 2024-03-07
Gallium-68 PSMA-11 PET in Participants With Prostate Cancer
CLINICAL_TRIALS study record update · 2023-11-29
A Phase I/II Study of Enzalutamide in Combination With Indomethacin in Castration-Resistant Prostate Cancer (CRPC)
CLINICAL_TRIALS study record update · 2023-10-26
Radiation Enhancement of Local and Systemic Anti-Prostate Cancer Immune Responses
CLINICAL_TRIALS study record update · 2023-10-18
A Phase I Study to Evaluate PSCA-Targeting Chimeric Antigen Receptor (CAR)-T Cells for Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer
CLINICAL_TRIALS study record update · 2023-10-16
Phase Ib/II Study of Enzalutamide With Venetoclax (ABT-199) in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
CLINICAL_TRIALS study record update · 2023-09-28
Erdafitinib Plus Abiraterone Acetate or Enzalutamide in Double Negative Prostate Cancer
CLINICAL_TRIALS study record update · 2023-09-21
A Phase I Study of AZD8186 in Combination With Docetaxel in Patients With PTEN Mutated or PIK3CB Mutated Advanced Solid Tumors, Potentially Amenable to Docetaxel
CLINICAL_TRIALS study record update · 2023-07-14
An Open-Label, Parallel, Phase II Study of Single-Agent Oral ESK981 in Men With Castrate-Resistant Prostate Cancer (CRPC)